— Know what they know.
Not Investment Advice

CTEV NYSE

Claritev Corporation
1W: -1.3% 1M: -6.6% 3M: -4.4% YTD: -36.1% 1Y: -67.4% 3Y: -66.8% 5Y: -88.7%
$22.63
+1.09 (+5.06%)
After Hours: $23.05 (+0.42, +1.83%)
Weekly Expected Move ±8.6%
$19 $21 $24 $26 $28
NYSE · Healthcare · Medical - Healthcare Information Services · Tech Score Sell · Power 38 · $365.0M mcap · 7M float · 2.11% daily turnover · Short 45% of daily vol
Credit Risk of going bust: higher than 96% of companies Debt: 92.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the riskiest tenth, about 1 in 20 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $18.94 (down 12%), Claritev Corporation would be worth roughly what it owes.
Total debt $4.62B against a stock market value of $365.0M.
Distance to default 0.10 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $2.32B (short-term plus half of long-term), stock volatility 127.1%; Altman Z'' -1.71. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Smart Money Score
Moderate 50
Insider+$0.7M
Congress—
ETF Holdings—
Key Statistics
Market Cap$365.0M
52W Range11.5-73.68
Volume420,464
Avg Volume145,630
Beta0.79
Dividend—
Analyst Ratings
5 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOTravis S. Dalton
Employees3,000
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2020-04-03
7900 Tysons One Place
McLean, VA 22102
US
(212) 780-2000
About Claritev Corporation

Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.

Recent Insider Trades

NameTypeSharesPriceDate
Main Jennifer Elizab A-Award 3,113 — 2026-10-15
Main Jennifer Elizab 0 — 2026-10-15
Misencik Tiffani S-Sale 5,812 $23.81 2026-10-15
Misencik Tiffani F-InKind 9,994 $23.94 2026-10-14
Garis Douglas Michae S-Sale 7,877 $30.50 2026-09-21

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms